First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors (Q46570196)
Jump to navigation
Jump to search
scientific article published on 21 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors |
scientific article published on 21 October 2014 |
Statements
1 reference
First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors (English)
1 reference
Geoffrey I Shapiro
1 reference
Eunice Kwak
1 reference
Bruce J Dezube
1 reference
Murray Yule
1 reference
John Ayrton
1 reference
John Lyons
1 reference
Daruka Mahadevan
1 reference
21 October 2014
1 reference
1 reference
21
1 reference
1
1 reference
87-97
1 reference
Identifiers
1 reference
1 reference